Skip to main content
Premium Trial:

Request an Annual Quote

Seeking Donations for Bacteria

Ubiome, a firm that is developing a technology to sequence human bacterial DNA, has turned to crowdfunding to raise the money it needs to sequence the human microbiome, MedCity News reports.

The company is asking individuals to contribute to its project on IndieGoGo. Their goal is to raise $95,000, the article says.

"It's 23andMe for the human microbiome," says Jessica Richman, a member of Ubiome's management team.

That's because those who contribute will have the opportunity to get their bugs tested before Ubiome hits the mainstream market. They will receive a swab-kit for five sites which each have a specific balance of flora: nose, ear, mouth, gastrointestinal tract, and genitalia, the article says.

The team will then sequence and analyze the samples. In time, the data will be used to make predictions about health, according to MedCity News.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.